AGA Leadership
AGA Leadership
Council Section Updates
Check out what’s new from the AGA Institute Council’s 13 sections! The council is responsible for the AGA Institute’s education program at Digestive Disease Week® (DDW), developing educational resources and holding events in targeted areas of practice throughout the year.
Updated as of February 2025.
Read the latest from AGA's sections
Top 3 Sessions
- Tech Tools for GI Practice
Saturday, May 3, 8–9:30 a.m.
Research Forum
As AI tools become available for clinicians in practice, it is important to understand their benefits and drawbacks. This session will address the status of tech tools for GI clinical practice. - Helicobacter pylori and Gastric Cancer: Optimizing Eradication Strategies, Prevention and Beyond
Saturday, May 3, 10–11:30 a.m.
Research Forum
H. Pylori is a risk factor for gastric cancer and challenging to eradicate. This session will review the latest guidance on treatment and association with outcomes such as reduction in risk of gastric cancer. - Day in the GI Office: What to Do Next for Common Presentations at the Gastroenterologist Office
Saturday, May 3, 4–5:30 p.m.
Clinical Symposium
Disorders of the gut brain axis (DGBIs) are commonly seen in outpatient GI practices. This session will review the management of common DGBIs in practice.
Top 3 Sessions
- Endoscopy, Technology & Imaging (ETI) Section Distinguished Abstract Plenary
Sunday, May 4, 10-11:30 a.m.
Plenary Session
Learn about recent advances in endoscopic technology and AI powered progress in endoscopic imaging. - Impact of AI on Endoscopic Practice in Gastroenterology: Hype or Reality
Saturday, May 3, 2-3:30 p.m.
Clinical Symposium
This session explores the latest data on the impact of AI in colon cancer screening, cancer detection in the esophagus, stomach, and small bowel, and the challenges associated with implementing AI technology in endoscopy practice. - Training, Credentialing and Mentoring in the Era of Interventional Endoscopy
Sunday, May 4, 2-3:30 p.m.
Clinical Symposium
This session covers the evolution of training in surgical endoscopy, with a focus on the training and credentialing processes for Interventional EUS, Metabolic Endoscopy, and POEM. It will also highlight key aspects of mentoring in advanced endoscopy to enhance skill development and clinical practice.
Top 3 Sessions
- Esophageal, Gastric & Duodenal Disorders (EGD) Section Distinguished Abstract Plenary
Monday, May 5, 2–3:30 p.m.
Plenary Session
This plenary session will review the best and highest scoring abstracts addressing advances in the diagnosis and management of common foregut disorders, including eosinophilic esophagitis, gastroesophageal reflux disease (GERD), Barrett’s esophagus, H. pylori infection and peptic ulcer disease. The presentations will discuss the role of GERD scoring systems in predicting success from antireflux surgery, the role of dupilumab in eosinophilic gastroenteritis, the use of capsule sponge for risk stratification in Barrett’s esophagus, the value of misoprostol in preventing peptic ulcer bleeding, and new insights into EoE pathogenesis as well as H. pylori eradication. - What’s New in Eosinophilic Esophagitis?
Saturday, May 3, 4–5:30 p.m.
Research Forum
This research forum will address new options in the management of eosinophilic esophagitis (EoE), from diet to biologics. Topics discussed include novel sampling of the esophagus to measure disease activity, how to address milk induced EoE, targeting diet therapy to esophageal pathophysiology, understanding adaptive behaviors adopted by patients using a novel questionnaire, and use of new drug delivery systems in managing the disease, including childhood EoE. - Advances in GERD Diagnosis
Sunday, May 4, 8-9:30 am
Research Forum
This research forum will delve into the role of clinical symptomatology, psychological factors and symptom scores to further personalize GERD diagnosis. The session will feature unique implementation of the Lyon score in lung transplant patients and in patients tested on PPI therapy, use of the esophageal hypervigilance and symptom specific anxiety score (EHAS score) in patients with laryngeal symptoms, discrimination of globus as predominantly a disorder of gut-brain interaction rather than reflux disease, and role of diaphragm function and the small bowel microbiome in gastroesophageal reflux disease.
Top 3 Sessions
- Omics for Mechanistic Understanding, Diagnosis and Disease Stratification in Inflammatory Bowel Diseases
Saturday, May 3, 4–5:30 p.m.
Research Forum
This session is dedicated to the use of omics to mechanistically understand and develop novel targets for inflammatory bowel disease as well as support diagnosis and disease stratification. - Immunology, Microbiology & Inflammatory Bowel Diseases (IMIBD) Section Distinguished Abstract Plenary
Monday, May 5, 2–3:30 p.m.
Plenary Session
This session will highlight the best of the best in basic and clinical science inflammatory bowel diseases research submitted to DDW 2025 and will cover novel genetic variants and gene expression patterns linked with disease, recent findings on the role of the gut microbiota on disease pathogenesis and the latest clinical trials controlled clinical trials in the field. - Clinical Trials
Clinical Trials in IBD: Biologics and Emerging Therapies
Monday, May 5, 4–5:30 p.m.
Research Forum
This session will examine state of the art pivotal trials on efficacy of various biologic therapies for management of IBD.
Clinical Trials in IBD: Small Molecules and Monitoring Strategies
Tuesday, May 6, 10–11:30 a.m.
Research Forum
This session will examine monitoring strategies for dysplasia detection in IBD, treatment targets in the VERDICT trial, and will compare small molecule therapy to steroids or biologic in IBD.
Top 3 Sessions
- Liver & Biliary (LB) Section Distinguished Abstract Plenary
Sunday, May 4, 4–5:30 p.m.
Plenary Session
This is a must attend session because it highlights an array of cutting-edge patient care advances in hepatology and liver disease. It also highlights advancements in hepatology and liver-related research. - Cirrhosis and Portal Hypertension
Saturday, May 3, 8–9:30 a.m.
Research Forum
This session will present novel information about complications of portal hypertension, including ascites, SBP and the hepatorenal syndrome. Additionally, this session includes cutting-edge evidence that promises to identify novel proteomic profiles that predict future clinical portal hypertensive events. - Alcohol-Associated Liver Disease
Tuesday, May 6, 10–11:30 a.m.
Research Forum
This session includes several presentations that promise to highlight novel interventions in patients’ alcohol use disorder and various forms of alcohol-associated liver disease. Specific topics will include the effectiveness of exercise, GLP-1 agonists, omega-5 fatty acids and oral naltrexone to mention a few.
Top 3 Sessions
- Josephine and Michael Camilleri, MD, Lecture: State of the Art
Sunday, May 4, 10–11:30 a.m.
Clinical Symposium
Luminaries of neurogastroenterology will share their perspective on the latest for esophageal/gastroduodenal/colonic issues. - Challenging Clinical Controversies in Neurogastroenterology
Sunday, May 4, 2–3:30 p.m.
Clinical Symposium
Hot topics debate style in neurogastroenterology where the audience can decide for themselves what is the “right” way to do things! - Neurogastroenterology & Motility (NGM) Section Distinguished Abstract Plenary
Monday, May 5, 4–5:30 p.m.
Plenary Session
Learn the latest about the top clinical developments and basic science research in neurogastroenterology and motility! Topics range from esophageal hypervigilance, gastroparesis, IBS, and insights into Interstitial cells of Cahal and Enterochromaffin cells as well as sexual dimorphism in gastrointestinal motility.
Top 3 Sessions
- AGA/ASPEN Joint Session: Food Avoidance/Restriction in GI Disorders
Monday, May 5, 10–11:30 a.m.
Clinical Symposium
This is a joint program co-hosted by ASPEN, DIGID, and the OMN section on basic interventions and mechanisms by which food avoidance and restrictive diets work. - To Cut or Not to Cut: The Role of Bariatric Procedures in the Age of Novel Anti-Obesity Medications
Sunday, May 4, 8–9:30 a.m.
Clinical Symposium
The debate session will highlight new literature and controversies with indications and complications of common surgical weight loss procedures as compared to anti-obesity medications. - Precision Medicine: Bringing the Science of Nutritional Therapy to the Clinic
Monday, May 5, 2–3:30 p.m.
Clinical Symposium
Sharing practical tips for practitioners that they can use in their clinics while managing nutritional interventions for common GI diseases.
Top 3 Sessions
- Advances in Pediatric Liver and Pancreatic Disease
Tuesday, May 6, 8–9:30 a.m.
Research Forum
Novel research and clinical developments in the field of pediatric liver disorders. - Shaping Form and Function of the Intestinal Epithelium
Saturday, May 3, 2–3:30 p.m.
Research Symposium
Explore the fascinating intersection of mechanical and biological forces that shape the morphogenesis of the intestine and influence the function of intestinal epithelial cells. - Imaging Modalities in Pediatric Gastroenterology: Where We Are and Where We Are Going
Sunday, May 4, 10–11:30 a.m.
Clinical Symposium
This session will review state-of-the-art imaging modalities that are used to diagnose and monitor pediatric gastroenterological diseases.
